Northwest Quadrant Wealth Management, LLC Nuvation Bio Inc. Transaction History
Northwest Quadrant Wealth Management, LLC
- $473 Million
- Q3 2025
A detailed history of Northwest Quadrant Wealth Management, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Northwest Quadrant Wealth Management, LLC holds 10,855 shares of NUVB stock, worth $52,755. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,855Holding current value
$52,755% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding NUVB
# of Institutions
218Shares Held
165MCall Options Held
1.99MPut Options Held
660K-
Decheng Capital LLC Menlo Park, CA26MShares$126 Million16.75% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$78.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$75.1 Million0.0% of portfolio
-
Laurion Capital Management LP New York, NY9.71MShares$47.2 Million0.67% of portfolio
-
Omega Fund Management, LLC Boston, MA8.83MShares$42.9 Million89.01% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $1.06B
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...